FROM Mary Claire King
Human Genetics: Medicine, Money and Law Billions of dollars have been raised for medical research because human genes can be patented so, when breakthroughs occur, investors make money. But early this week New York Federal Judge Robert W. Sweet rocked the bio-tech industry when he ruled that human genes cannot be patented because they are products of nature, not creative invention. The decision is both applauded for liberating the promising new field of personalized genomic medicine and criticized for limiting financial incentives. We hear a variety of answers to some very challenging questions.
Trump's new look at civil rights and global warming President Trump is reportedly ready to pull the US out of the Paris Agreement on Climate Change. We look at the possible consequences. On the second half of the program, we hear about cuts in Obama-Era civil rights programs called for by the Trump Administration's first budget plan.
Replacing Obamacare: Now you see it… now you don’t As the Senate deliberates replacing Obmacare, health coverage for millions of people is at stake. There've been no public hearings, and a draft measure won't be made public. Is the House version so unpopular that that Senate is hiding a version that looks much the same?